An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues

StatusActive, Not Recruiting
PhasePhase 1/2
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later Sep 2026 → Sep 2027
See other at-risk trials from Memorial Sloan Kettering Cancer Center

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Sep 2026 to Sep 2027
    • Eligibility criteria expanded, about 14 words
  2. Notable Primary and study completion dates: Sep 2025 to Sep 2026v7
  3. Notable Primary and study completion dates: Sep 2024 to Sep 2025v6
  4. Minor Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 8 of 8 sites
    v5
  5. Minor Interventions: Acupuncture (Procedure), Waitlist Control (Other) to Acupuncture (Procedure), Questionnaires (Other), Waitlist Control (Other)v4
Show 2 earlier versionsHide 2 earlier versions
  1. Minor Re-verified, no change to tracked fieldsv3
  2. Minor Eligibility criteria expanded, about 3 wordsv2
  1. Minor Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to test whether acupuncture can improve nocturia in prostate cancer survivors. This is the first time acupuncture is being studied for nocturia in prostate cancer survivors. Researchers will see if acupuncture is a practical treatment option for prostate cancer survivors with nocturia. The study will also look at the effect acupuncture has on nocturia and other symptoms prostate cancer survivors experience such as insomnia, hot flashes, anxiety, depression, tiredness (fatigue), sexual dysfunction, and cognitive (mental) difficulties.
Trial Details
NCT Number NCT05540392
Lead Sponsor Memorial Sloan Kettering Cancer Center
Conditions
(from sponsor)
Survivorship, Prostate Cancer
Related terms Nocturia, Prostatic Neoplasms
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov